Brief: Pledpharma: Positive Results From The Aladote PoP Study

Egetis Therapeutics AB (publ)

24/09/2018 07:33

Sept 24 (Reuters) - PledPharma AB (publ)  PLED.ST :
    * REG-PLEDPHARMA ANNOUNCES POSITIVE RESULTS FROM THE
ALADOTE®
PROOF OF PRINCIPLE STUDY
    * ALADOTE STUDY HAS SUCCESSFULLY MET PRIMARY ENDPOINT OF
SAFETY
AND TOLERABILITY
    * PLEDPHARMA - AS FOR SECONDARY ENDPOINTS, RESULTS INDICATE
POSITIVE SIGNAL OF REDUCED PARACETAMOL-INDUCED LIVER INJURY
    * WILL CONTINUE TO WORK ON DEVELOPMENT STRATEGY AND DESIGN
OF NEXT
STUDY
    * DECISION ON NEXT STEPS WILL BE TAKEN BEFORE YEAR END

Source text for Eikon:  ID:nGNE8j77sS 
Further company coverage:  PLED.ST 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))